Pre-clinical development and molecular characterization of an engineered type 1 regulatory T-cell product suitable for immunotherapy-Reference-Cited by-同舟云学术

Pre-clinical development and molecular characterization of an engineered type 1 regulatory T-cell product suitable for immunotherapy

Published:2021-11 Issue:11 Volume:23 Page:1017-1028
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Liu Jeffrey Mao-Hwa,Chen Ping,Uyeda Molly Javier,Cieniewicz Brandon,Sayitoglu Ece Canan,Thomas Benjamin Craig,Sato Yohei,Bacchetta Rosa,Cepika Alma-Martina,Roncarolo Maria Grazia

Funder

National Institutes of Health

Stanford Maternal and Child Health Research Institute

National Science Foundation

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference53 articles.

1. Dissecting the biology of allogeneic HSCT to enhance the GvT effect whilst minimizing GvHD;Blazar;Nat Rev Clin Oncol,2020

2. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells;Akdis;J Exp Med,2004

3. The role of allogeneic stem cell transplantation in the management of acute myeloid leukaemia: a triumph of hope and experience;Loke;Br J Haematol,2020

4. Cellular therapies for graft-versus-host disease: a tale of tissue repair and tolerance;Voermans;Blood,2020

5. Graft-versus-host disease versus graft-versus-leukemia;Negrin;Hematology Am Soc Hematol Educ Program 2015,2015

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AML/T cell interactomics uncover correlates of patient outcomes and the key role of ICAM1 in T cell killing of AML;Leukemia;2024-05-09

2. Immune modulation in transplant medicine: a comprehensive review of cell therapy applications and future directions;Frontiers in Immunology;2024-04-08

3. Hypomethylation-induced regulatory programs in T cells unveiled by transcriptomic analyses;Frontiers in Immunology;2023-09-27

4. AML/T cell interactomics uncover correlates of patient outcomes and the key role of ICAM1 in T cell killing of AML;2023-09-23

5. Erratum: Type 1 regulatory T cell-mediated tolerance in health and disease;Frontiers in Immunology;2023-01-24